MktsMarkets

KALA BIO, Inc.
NASDAQ: KALAKey statistics
KALA News
Stories mentioning KALA from around the web — every one is an open thread, so give it a like or add your take.
Loading news…
Financial statements
As filed, straight from the 10-Q — up to 19 years of history, free, with every line item chartable.
| Line item | Q1 '26Mar 31 | Q4 '25Dec 31 | Q3 '25Sep 30 | Q2 '25Jun 30 | Q1 '25Mar 31 | Q4 '24Dec 31 | Q3 '24Sep 30 | Q2 '24Jun 30 |
|---|---|---|---|---|---|---|---|---|
| Income Statement | ||||||||
| Revenue | ||||||||
| Cost of Goods Sold | ||||||||
| Gross Profit | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Expenses | ||||||||
| Research & Development | 61.00 | (18,414) | 6,127 | 6,232 | 6,055 | (16,836) | 5,168 | 5,317 |
| Sales General & Admin | ||||||||
| Total Operating Expenses | 1,802 | 10,225 | 7,239 | 11,028 | 10,669 | 9,459 | 9,988 | 9,605 |
| Operating Income (Loss) | (1,802) | (10,225) | (7,239) | (11,028) | (10,669) | (9,459) | (9,988) | (9,605) |
| Interest Income | 74.00 | 0.00 | 270.00 | 407.00 | 463.00 | 478.00 | 570.00 | 504.00 |
| Interest Expense | ||||||||
| Other Expense | 107.00 | (112.00) | ||||||
| Pretax Income | ||||||||
| Tax Provision | ||||||||
| Net Income (Loss) | (1,621) | 686.00 | (7,564) | (11,155) | (8,947) | (8,175) | (8,950) | (9,579) |
| Earnings Per Share (Basic) | (0.14) | 0.08 | (1.07) | (1.71) | (70.49) | (2.15) | (1.93) | (3.16) |
| Earnings Per Share (Diluted) | (0.14) | 0.08 | (1.07) | (1.71) | (70.49) | (2.15) | (1.93) | (3.16) |
| Weighted Average Shares Outstanding (Basic) | 11,874 | 8,148 | 7,042 | 6,513 | 127.00 | 3,796 | 4,628 | 3,030 |
| Weighted Average Shares Outstanding (Diluted) | 11,874 | 8,148 | 7,042 | 6,513 | 127.00 | 3,796 | 4,628 | 3,030 |
Scroll the table sideways for older periods — the line-item column and the period header stay put. Hover a row and use the chart handle to plot it over the full history.
About KALA
KALA BIO, Inc. (NASDAQ: KALA) is a stock listed on the Nasdaq Stock Market under the ticker symbol KALA. It last traded at $0.1600 (Nov 6, 2026, 4:00 PM ET), up 2.2% on the day. That gives KALA BIO a market capitalisation of $3.0M.
Over the past 52 weeks KALA has traded between $0.1100 and $95.50.
For the quarter ended Mar 31, 2026 it reported a net loss of $1.6M.
| Quarter ended | Revenue | Net income |
|---|---|---|
| Mar 31, 2026 | — | -$1.6M |
| Dec 31, 2025 | — | $686.0K |
| Sep 30, 2025 | — | -$7.6M |
| Jun 30, 2025 | — | -$11.2M |
From KALA BIO’s quarterly (10-Q) filings, in US dollars.
Take a break — play a market game
Seven free games built around the markets. No download, no sign-up: they run right here in your browser.
Latest News
Market news from around the web — every story is an open thread, so give it a like or add your take.
Loading news…